See if your practice qualifies →

Autoimmune and inflammatory disease is a major focus for drug and biologic developers. The patients these studies need are managed by rheumatologists, often for many years.

Whizz Health builds and runs the research program inside your practice. Your rheumatologists lead the studies. Our team handles the rest.

Conditions with active industry research

• Rheumatoid arthritis

• Psoriatic arthritis

• Lupus

• Axial spondyloarthritis

• Osteoarthritis

• Gout

• Sjögren's disease

What a study looks like in your office

Study visits

Studies bring patients back on a regular schedule for joint exams, labs, and study drug. The drug may be a pill, an injection, or an infusion.

Space and equipment

An exam room, and for infusion studies, an infusion chair with monitoring. If you already run an infusion suite, you have a head start.

Your physician's role

Many studies use standardized joint counts and disease-activity scores. Your investigator or a trained assessor performs them at set visits. We arrange the training.

What your practice needs

• An independent rheumatology practice

• A physician interested in serving as principal investigator

• Steady volume of patients with the conditions above

• An EHR that can run simple patient counts

No research experience is needed.

How it works

1. Free practice assessment. We review your patient volume, using simple counts from your own reports, and show you which studies fit.

2. Site setup and study matching. We prepare your site, place a trained coordinator, and present your practice to sponsors.

3. Run and enroll. Your coordinator pre-screens patients and manages visits. Your physician oversees the research.

What your practice gets

• A new revenue stream from sponsor-paid study work

• Research coordinators we hire, train, and manage

• Regulatory, contract, and billing work handled for you

• New treatment options for patients who want them

• No upfront cost

Running a rheumatology or autoimmune study? Submit it for a free feasibility review →